Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Impacts of Surgery on Symptom Burden and Quality of Life in Pituitary Tumor Patients in the Subacute Post-operative Period.

Waddle MR, Oudenhoven MD, Farin CV, Deal AM, Hoffman R, Yang H, Peterson J, Armstrong TS, Ewend MG, Wu J.

Front Oncol. 2019 Apr 23;9:299. doi: 10.3389/fonc.2019.00299. eCollection 2019.

2.

Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection.

Okolie O, Irvin DM, Bago JR, Sheets K, Satterlee A, Carey-Ewend AG, Lettry V, Dumitru R, Elton S, Ewend MG, Miller CR, Hingtgen SD.

PLoS One. 2018 Jul 10;13(7):e0198596. doi: 10.1371/journal.pone.0198596. eCollection 2018.

3.

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 Jun 29;16(1):179. doi: 10.1186/s12967-018-1552-1.

4.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 May 29;16(1):142. doi: 10.1186/s12967-018-1507-6. Erratum in: J Transl Med. 2018 Jun 29;16(1):179.

5.

The incidence and predictive factors for leptomeningeal spread after stereotactic radiation for breast cancer brain metastases.

Kaidar-Person O, Deal AM, Anders CK, Ewend MG, Dees EC, Camporeale J, Ramirez J, Benbow JM, Marks LB, Zagar TM.

Breast J. 2018 May;24(3):424-425. doi: 10.1111/tbj.12919. Epub 2017 Dec 18. No abstract available.

PMID:
29251377
6.

Obituary. Robert H. Wilkins, MD, 1934-2017.

Sampson JH, Haglund MM, Friedman AH, Ewend MG.

J Neurosurg. 2017 Dec;127(6):1457-1458. doi: 10.3171/2017.6.JNS171416. Epub 2017 Oct 13. No abstract available.

PMID:
29027856
7.

Pediatric Auditory Brainstem Implantation: Surgical, Electrophysiologic, and Behavioral Outcomes.

Teagle HFB, Henderson L, He S, Ewend MG, Buchman CA.

Ear Hear. 2018 Mar/Apr;39(2):326-336. doi: 10.1097/AUD.0000000000000501.

8.

Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.

Mounsey LA, Deal AM, Keith KC, Benbow JM, Shachar SS, Zagar T, Dees EC, Carey LA, Ewend MG, Anders CK.

Clin Breast Cancer. 2018 Feb;18(1):29-37. doi: 10.1016/j.clbc.2017.07.017. Epub 2017 Aug 9.

9.

MerTK as a therapeutic target in glioblastoma.

Wu J, Frady LN, Bash RE, Cohen SM, Schorzman AN, Su YT, Irvin DM, Zamboni WC, Wang X, Frye SV, Ewend MG, Sulman EP, Gilbert MR, Earp HS, Miller CR.

Neuro Oncol. 2018 Jan 10;20(1):92-102. doi: 10.1093/neuonc/nox111.

10.

The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy.

Kaidar-Person O, Zagar TM, Deal A, Moschos SJ, Ewend MG, Sasaki-Adams D, Lee CB, Collichio FA, Fried D, Marks LB, Chera BS.

Anticancer Drugs. 2017 Jul;28(6):669-675. doi: 10.1097/CAD.0000000000000497.

PMID:
28368903
11.

Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair.

Lu Y, Kwintkiewicz J, Liu Y, Tech K, Frady LN, Su YT, Bautista W, Moon SI, MacDonald J, Ewend MG, Gilbert MR, Yang C, Wu J.

Cancer Res. 2017 Apr 1;77(7):1709-1718. doi: 10.1158/0008-5472.CAN-16-2773. Epub 2017 Feb 15.

12.

Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.

Bagó JR, Okolie O, Dumitru R, Ewend MG, Parker JS, Werff RV, Underhill TM, Schmid RS, Miller CR, Hingtgen SD.

Sci Transl Med. 2017 Feb 1;9(375). pii: eaah6510. doi: 10.1126/scitranslmed.aah6510.

PMID:
28148846
13.

Multidisciplinary Management of Breast Cancer Brain Metastases.

Zagar TM, Van Swearingen AE, Kaidar-Person O, Ewend MG, Anders CK.

Oncology (Williston Park). 2016 Oct 15;30(10):923-33. Review.

14.

ACTIVITY OF TRASTUZUMAB-EMTANSINE (TDM1) IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A CASE SERIES.

Keith KC, Lee Y, Ewend MG, Zagar TM, Anders CK.

Cancer Treat Commun. 2016;7:43-46.

15.

Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.

Schmid RS, Simon JM, Vitucci M, McNeill RS, Bash RE, Werneke AM, Huey L, White KK, Ewend MG, Wu J, Miller CR.

Neuro Oncol. 2016 Jul;18(7):962-73. doi: 10.1093/neuonc/nov321. Epub 2016 Jan 28.

16.

A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience.

McKee MJ, Keith K, Deal AM, Garrett AL, Wheless AA, Green RL, Benbow JM, Dees EC, Carey LA, Ewend MG, Anders CK, Zagar TM.

Oncologist. 2016 Jan;21(1):16-20. doi: 10.1634/theoncologist.2015-0328. Epub 2015 Dec 9.

17.

Reconstruction of Skull Base Defects.

Klatt-Cromwell CN, Thorp BD, Del Signore AG, Ebert CS, Ewend MG, Zanation AM.

Otolaryngol Clin North Am. 2016 Feb;49(1):107-17. doi: 10.1016/j.otc.2015.09.006. Review.

PMID:
26614831
18.

Endoscopic sinonasal meningoencephalocele repair: a 13-year experience with stratification by defect and reconstruction type.

Rawal RB, Sreenath SB, Ebert CS Jr, Huang BY, Dugar DR, Ewend MG, Sasaki-Adams D, Senior BA, Zanation AM.

Otolaryngol Head Neck Surg. 2015 Feb;152(2):361-8. doi: 10.1177/0194599814561437.

PMID:
25645526
19.

Endoscopic endonasal approaches to infratemporal fossa tumors: a classification system and case series.

Taylor RJ, Patel MR, Wheless SA, McKinney KA, Stadler ME, Sasaki-Adams D, Ewend MG, Germanwala AV, Zanation AM.

Laryngoscope. 2014 Nov;124(11):2443-50. doi: 10.1002/lary.24638.

PMID:
25513678
20.

A multicenter retrospective study of frameless robotic radiosurgery for intracranial arteriovenous malformation.

Oermann EK, Murthy N, Chen V, Baimeedi A, Sasaki-Adams D, McGrail K, Collins SP, Ewend MG, Collins BT.

Front Oncol. 2014 Nov 4;4:298. doi: 10.3389/fonc.2014.00298. eCollection 2014.

21.

Effect of cochlear nerve electrocautery on the adult cochlear nucleus.

Iseli CE, Merwin WH 3rd, Klatt-Cromwell C, Hutson KA, Ewend MG, Adunka OF, Fitzpatrick DC, Buchman CA.

Otol Neurotol. 2015 Apr;36(4):670-7. doi: 10.1097/MAO.0000000000000588.

PMID:
25280052
22.

Endoscopic endonasal transclival approaches: case series and outcomes for different clival regions.

Little RE, Taylor RJ, Miller JD, Ambrose EC, Germanwala AV, Sasaki-Adams DM, Ewend MG, Zanation AM.

J Neurol Surg B Skull Base. 2014 Aug;75(4):247-54. doi: 10.1055/s-0034-1371522. Epub 2014 Apr 17.

23.

The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implications.

Sharpton SR, Oermann EK, Moore DT, Schreiber E, Hoffman R, Morris DE, Ewend MG.

Neurosurgery. 2014 Jan;74(1):9-15; discussion 16; quiz 16. doi: 10.1227/NEU.0000000000000190.

PMID:
24077581
24.

Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafers.

Brem S, Meyers CA, Palmer G, Booth-Jones M, Jain S, Ewend MG.

Cancer. 2013 Nov 1;119(21):3830-8. doi: 10.1002/cncr.28307. Epub 2013 Aug 23.

25.

The impact of radiosurgery fractionation and tumor radiobiology on the local control of brain metastases.

Oermann EK, Kress MA, Todd JV, Collins BT, Hoffman R, Chaudhry H, Collins SP, Morris D, Ewend MG.

J Neurosurg. 2013 Nov;119(5):1131-8. doi: 10.3171/2013.8.JNS122177. Epub 2013 Sep 6.

PMID:
24010977
26.

Beyond the nasoseptal flap: outcomes and pearls with secondary flaps in endoscopic endonasal skull base reconstruction.

Patel MR, Taylor RJ, Hackman TG, Germanwala AV, Sasaki-Adams D, Ewend MG, Zanation AM.

Laryngoscope. 2014 Apr;124(4):846-52. doi: 10.1002/lary.24319. Epub 2014 Jan 15.

PMID:
23877996
27.

Stereotactic radiosurgery for single brain metastases from non-small cell lung cancer: progression of extracranial disease correlates with distant intracranial failure.

Kress MA, Oermann E, Ewend MG, Hoffman RB, Chaudhry H, Collins B.

Radiat Oncol. 2013 Mar 19;8:64. doi: 10.1186/1748-717X-8-64.

28.

Predicting survival in patients with brain metastases treated with radiosurgery using artificial neural networks.

Oermann EK, Kress MA, Collins BT, Collins SP, Morris D, Ahalt SC, Ewend MG.

Neurosurgery. 2013 Jun;72(6):944-51; discussion 952. doi: 10.1227/NEU.0b013e31828ea04b.

PMID:
23467250
29.

Comparative analysis of cost of endoscopic endonasal minimally invasive and sublabial-transseptal approaches to the pituitary.

Oosmanally N, Paul JE, Zanation AM, Ewend MG, Senior BA, Ebert CS Jr.

Int Forum Allergy Rhinol. 2011 Jul-Aug;1(4):242-9. doi: 10.1002/alr.20048. Epub 2011 Apr 28. Review.

PMID:
22287427
30.

Sinonasal quality-of-life before and after endoscopic, endonasal, minimally invasive pituitary surgery.

Suberman TA, Zanation AM, Ewend MG, Senior BA, Ebert CS Jr.

Int Forum Allergy Rhinol. 2011 May-Jun;1(3):161-6. doi: 10.1002/alr.20029. Epub 2011 Apr 26.

PMID:
22287366
31.

Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases.

Adamo B, Deal AM, Burrows E, Geradts J, Hamilton E, Blackwell KL, Livasy C, Fritchie K, Prat A, Harrell JC, Ewend MG, Carey LA, Miller CR, Anders CK.

Breast Cancer Res. 2011;13(6):R125. doi: 10.1186/bcr3071. Epub 2011 Dec 1.

32.

Approach-specific multi-grid anatomical modeling for neurosurgery simulation with public-domain and open-source software.

Audette MA, Rivière D, Law C, Ibanez L, Aylward SR, Finet J, Wu X, Ewend MG.

Proc SPIE Int Soc Opt Eng. 2011 Mar 1;7964. pii: 79642J.

33.

The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.

Anders CK, Deal AM, Miller CR, Khorram C, Meng H, Burrows E, Livasy C, Fritchie K, Ewend MG, Perou CM, Carey LA.

Cancer. 2011 Apr 15;117(8):1602-11. doi: 10.1002/cncr.25746. Epub 2010 Nov 29.

34.

Anatomical considerations for endoscopic endonasal skull base surgery in pediatric patients.

Tatreau JR, Patel MR, Shah RN, McKinney KA, Wheless SA, Senior BA, Ewend MG, Germanwala AV, Ebert CS Jr, Zanation AM.

Laryngoscope. 2010 Sep;120(9):1730-7. doi: 10.1002/lary.20964.

PMID:
20717950
35.

Cost effectiveness of a clinical pharmacist on a neurosurgical team.

Weant KA, Armitstead JA, Ladha AM, Sasaki-Adams D, Hadar EJ, Ewend MG.

Neurosurgery. 2009 Nov;65(5):946-50; discussion 950-1. doi: 10.1227/01.NEU.0000347090.22818.35.

PMID:
19834408
36.

Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?

Kimple RJ, Grabowski S, Papez M, Collichio F, Ewend MG, Morris DE.

Am J Clin Oncol. 2010 Jun;33(3):265-70. doi: 10.1097/COC.0b013e3181a76a24.

PMID:
19823072
37.

A compact VEGF signature associated with distant metastases and poor outcomes.

Hu Z, Fan C, Livasy C, He X, Oh DS, Ewend MG, Carey LA, Subramanian S, West R, Ikpatt F, Olopade OI, van de Rijn M, Perou CM.

BMC Med. 2009 Mar 16;7:9. doi: 10.1186/1741-7015-7-9.

38.

Minimally invasive pituitary surgery.

Senior BA, Ebert CS, Bednarski KK, Bassim MK, Younes M, Sigounas D, Ewend MG.

Laryngoscope. 2008 Oct;118(10):1842-55. doi: 10.1097/MLG.0b013e31817e2c43.

PMID:
18806476
39.

Guidelines for the initial management of metastatic brain tumors: role of surgery, radiosurgery, and radiation therapy.

Ewend MG, Morris DE, Carey LA, Ladha AM, Brem S.

J Natl Compr Canc Netw. 2008 May;6(5):505-13; quiz 514.

PMID:
18492462
40.

Predictors and incidence of central diabetes insipidus after endoscopic pituitary surgery.

Sigounas DG, Sharpless JL, Cheng DM, Johnson TG, Senior BA, Ewend MG.

Neurosurgery. 2008 Jan;62(1):71-8; discussion 78-9. doi: 10.1227/01.NEU.0000311063.10745.D8.

PMID:
18300893
41.

Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study.

Bullitt E, Lin NU, Smith JK, Zeng D, Winer EP, Carey LA, Lin W, Ewend MG.

Radiology. 2007 Dec;245(3):824-30. Epub 2007 Oct 22.

42.

Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control.

Ewend MG, Brem S, Gilbert M, Goodkin R, Penar PL, Varia M, Cush S, Carey LA.

Clin Cancer Res. 2007 Jun 15;13(12):3637-41.

43.

Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancer.

Bullitt E, Lin NU, Ewend MG, Zeng D, Winer EP, Carey LA, Smith JK.

Med Image Comput Comput Assist Interv. 2006;9(Pt 2):561-8.

44.

Secondary intracanalicular extension of a primary intracochlear schwannoma.

Bassim MK, Ewend MG, Buchman CA.

Otol Neurotol. 2007 Sep;28(6):863-4. No abstract available.

PMID:
17287652
45.

Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer.

Kwock L, Smith JK, Castillo M, Ewend MG, Collichio F, Morris DE, Bouldin TW, Cush S.

Lancet Oncol. 2006 Oct;7(10):859-68. Review.

PMID:
17012048
46.

The molecular portraits of breast tumors are conserved across microarray platforms.

Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM.

BMC Genomics. 2006 Apr 27;7:96.

47.

Current treatment paradigms for the management of patients with brain metastases.

Ewend MG, Elbabaa S, Carey LA.

Neurosurgery. 2005 Nov;57(5 Suppl):S66-77; discusssion S1-4. Review.

PMID:
16237291
48.

Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer.

Weigelt B, Hu Z, He X, Livasy C, Carey LA, Ewend MG, Glas AM, Perou CM, Van't Veer LJ.

Cancer Res. 2005 Oct 15;65(20):9155-8.

49.

Vessel tortuosity and brain tumor malignancy: a blinded study.

Bullitt E, Zeng D, Gerig G, Aylward S, Joshi S, Smith JK, Lin W, Ewend MG.

Acad Radiol. 2005 Oct;12(10):1232-40.

50.

Increased role of the otolaryngologist in endoscopic pituitary surgery: endoscopic hydroscopy of the sella.

Senior BA, Dubin MG, Sonnenburg RE, Melroy CT, Ewend MG.

Am J Rhinol. 2005 Mar-Apr;19(2):181-4.

PMID:
15921218

Supplemental Content

Loading ...
Support Center